Network Pharmacology, Molecular Modeling, and Surface Plasmon Resonance Combined with In Vitro Validation to Elucidate the Anti-Inflammatory Effects of Delphinidin in LPS-Stimulated Macrophages: Potential Relevance to Vascular Disease

Macrophage-driven inflammation is an important contributor to the development and progression of chronic vascular diseases. Although statins substantially reduce cardiovascular risk, residual inflammatory risk and treatment-related limitations highlight the need for complementary anti-inflammatory strategies. Delphinidin (Dp), a naturally occurring anthocyanidin found in several medicinal plants used in traditional Chinese medicine, exhibits anti-inflammatory activity; however, its effects on macrophage inflammatory signaling and their potential relevance to vascular inflammation remain incompletely understood. This study integrated network pharmacology, molecular docking, molecular dynamics simulations, surface plasmon resonance (SPR), and in vitro experiments to elucidate the mechanisms underlying Dp-mediated regulation of macrophage inflammation. Network analyses identified AKT1 as a candidate target and the PI3K/Akt signaling pathway as a potential regulatory mechanism. Molecular docking and molecular dynamics simulations suggested a structurally plausible interaction between Dp and AKT1, and SPR analysis provided experimental evidence of direct binding between Dp and AKT1. In lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages, Dp reduced NO production and the levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Dp also decreased the phosphorylation of PI3K (p-PI3K), Akt (p-Akt), and NF-κB (p-NF-κB), while pharmacological interventions further supported the involvement of the PI3K/Akt/NF-κB signaling pathway. Collectively, these findings suggest that Dp attenuates macrophage inflammatory responses, at least in part, by modulating this signaling pathway. These findings provide a basis for further investigation of the anti-inflammatory effects of Dp in macrophages and their potential relevance to vascular inflammation.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210440
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Network Pharmacology, Molecular Modeling, and Surface Plasmon Resonance Combined with In Vitro Validation to Elucidate the Anti-Inflammatory Effects of Delphinidin in LPS-Stimulated Macrophages: Potential Relevance to Vascular Disease

Lingran Feng, Tingxuan Zheng, Yiqian Zhang, Long Yao et al.
International Journal of Molecular Sciences
Computational Drug Discovery Methods
article

Network Pharmacology, Molecular Modeling, and Surface Plasmon Resonance Combined with In Vitro Validation to Elucidate the Anti-Inflammatory Effects of Delphinidin in LPS-Stimulated Macrophages: Potential Relevance to Vascular Disease

Lingran Feng, Tingxuan Zheng, Yiqian Zhang, Long Yao, Dongmei Yang, Haomin Li, Sihan Jia
article en

Abstract

Macrophage-driven inflammation is an important contributor to the development and progression of chronic vascular diseases. Although statins substantially reduce cardiovascular risk, residual inflammatory risk and treatment-related limitations highlight the need for complementary anti-inflammatory strategies. Delphinidin (Dp), a naturally occurring anthocyanidin found in several medicinal plants used in traditional Chinese medicine, exhibits anti-inflammatory activity; however, its effects on macrophage inflammatory signaling and their potential relevance to vascular inflammation remain incompletely understood. This study integrated network pharmacology, molecular docking, molecular dynamics simulations, surface plasmon resonance (SPR), and in vitro experiments to elucidate the mechanisms underlying Dp-mediated regulation of macrophage inflammation. Network analyses identified AKT1 as a candidate target and the PI3K/Akt signaling pathway as a potential regulatory mechanism. Molecular docking and molecular dynamics simulations suggested a structurally plausible interaction between Dp and AKT1, and SPR analysis provided experimental evidence of direct binding between Dp and AKT1. In lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages, Dp reduced NO production and the levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Dp also decreased the phosphorylation of PI3K (p-PI3K), Akt (p-Akt), and NF-κB (p-NF-κB), while pharmacological interventions further supported the involvement of the PI3K/Akt/NF-κB signaling pathway. Collectively, these findings suggest that Dp attenuates macrophage inflammatory responses, at least in part, by modulating this signaling pathway. These findings provide a basis for further investigation of the anti-inflammatory effects of Dp in macrophages and their potential relevance to vascular inflammation.

International Journal of Molecular SciencesVol. 27(22)
Hunan University of Traditional Chinese Medicine (CN)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon